序号 |
标题 |
次数 |
作者 |
发布时间 |
71101 |
mPEG7-NH2,甲氧基七聚乙二醇-氨基 |
114 |
wyh |
2024-12-25 |
71102 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
118 |
WYQ |
2024-12-25 |
71103 |
N3-PEG4-C2-Pfp ester,1353012-00-6,抗体- 药物偶联物 |
68 |
hyy |
2024-12-25 |
71104 |
cas:341498-08-6,N-Succinimidyl 4-(2-pyridyldithio)pentanoate |
93 |
h |
2024-12-25 |
71105 |
mPEG16-NH2 ,cas:907577-50-8 ,甲氧基十六聚乙二醇-氨基 |
102 |
wyh |
2024-12-25 |
71106 |
cas:115088-06-7,N-Succinimidyl 4-(2-pyridyldithio)butanoate |
98 |
h |
2024-12-25 |
71107 |
mPEG48-Br,甲氧基四十八聚乙二醇溴代 |
78 |
wyh |
2024-12-25 |
71108 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
100 |
WYQ |
2024-12-25 |
71109 |
mPEG11-Br,溴代十一甘醇单甲醚 |
67 |
wyh |
2024-12-25 |
71110 |
NHS-PEG4-azide,叠氮-PEG4-NHS酯,944251-24-5 ,ADC试剂 |
79 |
hyy |
2024-12-25 |
71111 |
cas:1610769-13-5,4-((S)-2-((S)-2-amino-3- methylbutanamido)-5- ureidopentanamido)benzyl 2-(pyridin- 2-yldisulfanyl)ethylcarbamate |
91 |
h |
2024-12-25 |
71112 |
mPEG4-OCH2COOH的结构特点,16024-66-1 |
100 |
wyh |
2024-12-25 |
71113 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
69 |
WYQ |
2024-12-25 |
71114 |
四苯基钯卟啉(Pd TPP),卟啉类化合物 |
158 |
WYQ |
2024-12-25 |
71115 |
N3-PEG3-C2-NHS ester,1245718-89-1,抗体- 药物偶联物 |
77 |
hyy |
2024-12-25 |
71116 |
cas:2353409-52-4 Mal-amido-PEG8-val-gly-PAB-OH |
55 |
h |
2024-12-25 |
71117 |
mPEG24-NH-Mal ,甲氧基二十四聚乙二醇-NH-马来酰亚胺 |
70 |
wyh |
2024-12-25 |
71118 |
cas:330970-70-2 Alloc-Val-Ala-OH,抗体偶联药物 |
71 |
h |
2024-12-25 |
71119 |
mPEG3-SH ,甲氧基三聚乙二醇-巯基 |
88 |
wyh |
2024-12-25 |
71120 |
cas:150114-97-9 Fmoc-Val-Ala-OH,抗体偶联药物 |
92 |
h |
2024-12-25 |
71121 |
N3-PEG2-C2-NHS ester,1312309-64-0,ADC试剂 |
70 |
hyy |
2024-12-25 |
71122 |
Methyltetrazine-CH2NHCO-PEG12-CH2CH2NH2 |
66 |
zyl |
2024-12-25 |
71123 |
mPEG11-OH,甲氧基十一聚乙二醇-羟基 |
66 |
wyh |
2024-12-25 |
71124 |
cas:70396-18-8 Boc-Val-Ala-OH,抗体偶联药物 |
77 |
h |
2024-12-25 |
71125 |
cas:2348405-93-4 DBCO-PEG4-Val-Ala-PAB-PNP,抗体偶联药物 |
75 |
h |
2024-12-25 |
71126 |
mPEG5-OH , 甲氧基五聚乙二醇-羟基 |
66 |
wyh |
2024-12-25 |
71127 |
cas:2762519-08-2 endo-BCN-PEG4-Val-Cit-PAB-MMAE |
83 |
h |
2024-12-25 |
71128 |
Methyltetrazine-CH2NHCO-PEG7-CH2CH2NH2 |
66 |
zyl |
2024-12-25 |
71129 |
mPEG12-CH2C≡CH,单甲氧基十二聚乙二醇炔基 |
78 |
wyh |
2024-12-25 |
71130 |
Azido-PEG4-MMAE,抗体偶联药物 |
67 |
h |
2024-12-25 |
71131 |
FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne |
88 |
h |
2024-12-25 |
71132 |
Methyltetrazine-CH2NHCO-PEG2-CH2CH2NH2的介绍 |
109 |
zyl |
2024-12-25 |
71133 |
mPEG48-OCH2CH2COONHS Ester的结构特点 |
141 |
wyh |
2024-12-25 |
71134 |
cas:2226472-28-0 DBCO-PEG4-Val-Cit-PAB-PNP,抗体偶联药物 |
92 |
h |
2024-12-25 |
71135 |
endo BCN-PEG3-Val-Cit,抗体偶联药物 |
63 |
h |
2024-12-25 |
71136 |
4-Azido-2,3,5,6-tetrafluorobenzoic Acid N-Succinimidyl ester,126695-58-7,抗体- 药物偶联物 |
93 |
hyy |
2024-12-25 |
71137 |
mPEG12-OCH2CH2COONHS Ester,甲氧基十二聚乙二醇琥珀酰亚胺丙酸酯 |
85 |
wyh |
2024-12-25 |
71138 |
Methyltetrazine-CH2NHCO-PEG8-N3的介绍 |
83 |
zyl |
2024-12-25 |
71139 |
cas:2055047-18-0 Azido-PEG3-Val-Cit-PAB-PNP,抗体偶联药物 |
75 |
h |
2024-12-25 |
71140 |
mPEG7-OCH2CH2COONHS Ester,甲氧基七聚乙二醇琥珀酰亚胺丙酸酯 |
92 |
wyh |
2024-12-25 |
71141 |
cas:1949793-41-2 Mal-amido-PEG4-Val-Cit-PAB-OH,抗体偶联药物 |
83 |
h |
2024-12-25 |
71142 |
Methyltetrazine-CH2NHCO-PEG3-N3 |
71 |
zyl |
2024-12-25 |
71143 |
mPEG2-OCH2CH2COONHS Ester,甲氧基二聚乙二醇琥珀酰亚胺丙酸酯 |
83 |
wyh |
2024-12-25 |
71144 |
Mal-PEG2-Val-Ala-PAB-PNP,抗体偶联药物 |
77 |
h |
2024-12-25 |
71145 |
cas:2249935-92-8 Mal-PEG1-Val-Cit-PAB-PNP,抗体偶联药物 |
78 |
h |
2024-12-25 |